| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urea Cycle Disorders, Inborn | 23 | 2023 | 80 | 6.560 |
Why?
|
| Osteogenesis Imperfecta | 19 | 2023 | 140 | 4.580 |
Why?
|
| Phenylbutyrates | 12 | 2023 | 59 | 3.650 |
Why?
|
| Argininosuccinic Aciduria | 13 | 2023 | 52 | 3.010 |
Why?
|
| Argininosuccinate Lyase | 14 | 2021 | 66 | 2.200 |
Why?
|
| Hyperammonemia | 13 | 2023 | 68 | 2.070 |
Why?
|
| Chromosome Deletion | 8 | 2014 | 1005 | 1.280 |
Why?
|
| Glutamine | 9 | 2018 | 299 | 1.170 |
Why?
|
| Glycerol | 6 | 2019 | 99 | 1.060 |
Why?
|
| Abnormalities, Multiple | 8 | 2018 | 998 | 0.960 |
Why?
|
| Phenylketonurias | 1 | 2023 | 23 | 0.930 |
Why?
|
| Developmental Disabilities | 7 | 2012 | 674 | 0.910 |
Why?
|
| Retinitis Pigmentosa | 1 | 2024 | 79 | 0.910 |
Why?
|
| Liver Transplantation | 7 | 2023 | 1112 | 0.880 |
Why?
|
| Ammonia | 7 | 2015 | 88 | 0.870 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 144 | 0.850 |
Why?
|
| Arginine | 10 | 2023 | 500 | 0.830 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2021 | 442 | 0.790 |
Why?
|
| Liver Diseases | 4 | 2021 | 574 | 0.750 |
Why?
|
| Bone Diseases, Developmental | 2 | 2018 | 70 | 0.740 |
Why?
|
| Citrulline | 4 | 2023 | 108 | 0.730 |
Why?
|
| Child, Preschool | 30 | 2021 | 16273 | 0.710 |
Why?
|
| Child | 41 | 2023 | 29154 | 0.700 |
Why?
|
| Gene Rearrangement | 4 | 2015 | 783 | 0.690 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2015 | 641 | 0.670 |
Why?
|
| Ethmoid Bone | 1 | 2018 | 14 | 0.660 |
Why?
|
| Sphenoid Bone | 1 | 2018 | 22 | 0.650 |
Why?
|
| Fractures, Bone | 5 | 2023 | 291 | 0.630 |
Why?
|
| Nitric Oxide | 6 | 2023 | 644 | 0.620 |
Why?
|
| Body Height | 1 | 2018 | 231 | 0.600 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2014 | 94 | 0.590 |
Why?
|
| Body Weight | 2 | 2020 | 1293 | 0.590 |
Why?
|
| Neurofibromatosis 1 | 1 | 2018 | 144 | 0.580 |
Why?
|
| Comparative Genomic Hybridization | 12 | 2015 | 691 | 0.570 |
Why?
|
| Benzoates | 1 | 2017 | 136 | 0.570 |
Why?
|
| Phenotype | 13 | 2022 | 6295 | 0.560 |
Why?
|
| Teriparatide | 4 | 2023 | 11 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2011 | 254 | 0.530 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2015 | 16 | 0.530 |
Why?
|
| Steroid Isomerases | 1 | 2015 | 13 | 0.530 |
Why?
|
| Collagen Type I | 5 | 2021 | 204 | 0.530 |
Why?
|
| Adolescent | 27 | 2021 | 31252 | 0.510 |
Why?
|
| Argininosuccinate Synthase | 4 | 2019 | 54 | 0.500 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 1054 | 0.500 |
Why?
|
| Male | 55 | 2024 | 123000 | 0.490 |
Why?
|
| Alopecia | 1 | 2015 | 126 | 0.490 |
Why?
|
| Dwarfism | 1 | 2015 | 109 | 0.480 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 799 | 0.480 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 941 | 0.480 |
Why?
|
| Humans | 86 | 2024 | 261506 | 0.470 |
Why?
|
| Base Sequence | 6 | 2015 | 4917 | 0.460 |
Why?
|
| Young Adult | 18 | 2021 | 21445 | 0.460 |
Why?
|
| Hearing Loss | 2 | 2019 | 153 | 0.460 |
Why?
|
| DNA Copy Number Variations | 7 | 2017 | 1516 | 0.460 |
Why?
|
| Bone Density | 8 | 2023 | 476 | 0.450 |
Why?
|
| Adult | 35 | 2023 | 77950 | 0.440 |
Why?
|
| Quality of Life | 5 | 2023 | 4532 | 0.440 |
Why?
|
| Cataract | 1 | 2015 | 218 | 0.440 |
Why?
|
| Sequence Deletion | 2 | 2015 | 875 | 0.440 |
Why?
|
| Infant | 20 | 2021 | 13310 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2014 | 179 | 0.420 |
Why?
|
| Female | 53 | 2021 | 141928 | 0.410 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2012 | 126 | 0.410 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2011 | 36 | 0.410 |
Why?
|
| Citrullinemia | 3 | 2020 | 19 | 0.410 |
Why?
|
| Self Report | 1 | 2015 | 756 | 0.400 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 96 | 0.400 |
Why?
|
| Cross-Over Studies | 5 | 2021 | 460 | 0.390 |
Why?
|
| Chromosome Aberrations | 3 | 2011 | 1960 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2012 | 327 | 0.390 |
Why?
|
| Urea | 4 | 2023 | 290 | 0.370 |
Why?
|
| Pediatrics | 1 | 2019 | 1141 | 0.370 |
Why?
|
| Genes, X-Linked | 2 | 2024 | 66 | 0.370 |
Why?
|
| Microcephaly | 3 | 2012 | 325 | 0.360 |
Why?
|
| Chromosome Duplication | 1 | 2010 | 157 | 0.360 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2009 | 14 | 0.350 |
Why?
|
| Cognition Disorders | 2 | 2012 | 786 | 0.350 |
Why?
|
| Gene Dosage | 1 | 2012 | 829 | 0.340 |
Why?
|
| Phenylacetates | 2 | 2013 | 20 | 0.340 |
Why?
|
| Metabolism, Inborn Errors | 2 | 2021 | 108 | 0.330 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 143 | 0.330 |
Why?
|
| Infant, Newborn | 15 | 2021 | 8223 | 0.310 |
Why?
|
| Bone Density Conservation Agents | 2 | 2023 | 198 | 0.300 |
Why?
|
| Lung | 1 | 2018 | 3151 | 0.300 |
Why?
|
| Biomarkers | 9 | 2021 | 5047 | 0.290 |
Why?
|
| Enterocytes | 2 | 2018 | 68 | 0.280 |
Why?
|
| Middle Aged | 19 | 2024 | 86204 | 0.270 |
Why?
|
| Proteins | 2 | 2023 | 1963 | 0.270 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2017 | 268 | 0.270 |
Why?
|
| Genetic Testing | 4 | 2024 | 1589 | 0.270 |
Why?
|
| North America | 4 | 2019 | 314 | 0.270 |
Why?
|
| Chromosome Breakage | 4 | 2016 | 226 | 0.260 |
Why?
|
| Cohort Studies | 6 | 2021 | 9244 | 0.260 |
Why?
|
| Metabolomics | 2 | 2019 | 478 | 0.260 |
Why?
|
| Severity of Illness Index | 6 | 2022 | 4320 | 0.260 |
Why?
|
| Segmental Duplications, Genomic | 4 | 2015 | 83 | 0.250 |
Why?
|
| Genetic Therapy | 1 | 2012 | 1616 | 0.240 |
Why?
|
| Argininosuccinic Acid | 3 | 2012 | 7 | 0.240 |
Why?
|
| Hyperargininemia | 2 | 2015 | 13 | 0.240 |
Why?
|
| Diphosphonates | 3 | 2023 | 262 | 0.240 |
Why?
|
| Genome, Human | 3 | 2017 | 1869 | 0.230 |
Why?
|
| Neonatal Screening | 5 | 2020 | 165 | 0.230 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2022 | 34 | 0.220 |
Why?
|
| Eye Proteins | 1 | 2024 | 269 | 0.210 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 5687 | 0.210 |
Why?
|
| Gene Duplication | 4 | 2015 | 421 | 0.210 |
Why?
|
| Liver | 5 | 2021 | 2961 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 1084 | 0.210 |
Why?
|
| Orthomyxoviridae | 1 | 2022 | 94 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 543 | 0.210 |
Why?
|
| Biosensing Techniques | 1 | 2022 | 75 | 0.200 |
Why?
|
| Dopaminergic Neurons | 1 | 2021 | 51 | 0.200 |
Why?
|
| Exons | 2 | 2017 | 1328 | 0.200 |
Why?
|
| Nitric Acid | 1 | 2021 | 8 | 0.200 |
Why?
|
| Mice | 17 | 2023 | 34495 | 0.190 |
Why?
|
| Bone and Bones | 2 | 2022 | 619 | 0.190 |
Why?
|
| Human Development | 1 | 2020 | 8 | 0.190 |
Why?
|
| Hypertension | 3 | 2018 | 1503 | 0.190 |
Why?
|
| Disease Models, Animal | 10 | 2023 | 7222 | 0.190 |
Why?
|
| Liver Glycogen | 1 | 2020 | 31 | 0.180 |
Why?
|
| Locus Coeruleus | 1 | 2019 | 33 | 0.180 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2019 | 81 | 0.180 |
Why?
|
| Animals | 21 | 2023 | 59536 | 0.170 |
Why?
|
| Mobility Limitation | 1 | 2019 | 31 | 0.170 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 36 | 0.170 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 130 | 0.170 |
Why?
|
| Chronic Pain | 1 | 2022 | 238 | 0.170 |
Why?
|
| Quality Improvement | 1 | 2016 | 851 | 0.170 |
Why?
|
| Genotype | 4 | 2020 | 4109 | 0.170 |
Why?
|
| Chromosome Disorders | 1 | 2011 | 417 | 0.170 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2018 | 362 | 0.170 |
Why?
|
| Osteoblasts | 1 | 2021 | 370 | 0.170 |
Why?
|
| Chromosome Mapping | 3 | 2011 | 1471 | 0.160 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 171 | 0.160 |
Why?
|
| Spirometry | 1 | 2018 | 143 | 0.160 |
Why?
|
| Vital Capacity | 1 | 2018 | 131 | 0.160 |
Why?
|
| Endothelial Cells | 3 | 2023 | 1048 | 0.160 |
Why?
|
| Encephalocele | 1 | 2018 | 53 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2022 | 398 | 0.160 |
Why?
|
| Glycolysis | 1 | 2021 | 519 | 0.160 |
Why?
|
| Arginase | 2 | 2015 | 48 | 0.160 |
Why?
|
| Cognition | 2 | 2019 | 968 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 6 | 2018 | 6942 | 0.150 |
Why?
|
| Respiratory Function Tests | 1 | 2018 | 318 | 0.150 |
Why?
|
| Nitrogen | 1 | 2017 | 162 | 0.150 |
Why?
|
| Nitrogen Isotopes | 1 | 2017 | 60 | 0.150 |
Why?
|
| Frontal Lobe | 1 | 2018 | 187 | 0.150 |
Why?
|
| Rothmund-Thomson Syndrome | 1 | 2017 | 54 | 0.150 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 314 | 0.150 |
Why?
|
| Deuterium | 1 | 2017 | 111 | 0.150 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 187 | 0.150 |
Why?
|
| Cesarean Section | 2 | 2021 | 367 | 0.150 |
Why?
|
| Alanine Transaminase | 2 | 2020 | 227 | 0.150 |
Why?
|
| Orbit | 1 | 2018 | 205 | 0.150 |
Why?
|
| Isotope Labeling | 1 | 2017 | 142 | 0.150 |
Why?
|
| Syndrome | 4 | 2018 | 1351 | 0.140 |
Why?
|
| Mutation | 8 | 2020 | 15179 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2012 | 2508 | 0.140 |
Why?
|
| Carbon Isotopes | 1 | 2017 | 333 | 0.140 |
Why?
|
| Molecular Docking Simulation | 1 | 2016 | 144 | 0.140 |
Why?
|
| Species Specificity | 1 | 2017 | 777 | 0.130 |
Why?
|
| Motor Activity | 1 | 2019 | 693 | 0.130 |
Why?
|
| Aspartic Acid | 1 | 2015 | 126 | 0.130 |
Why?
|
| Swine | 2 | 2017 | 1541 | 0.130 |
Why?
|
| Double-Blind Method | 3 | 2014 | 2588 | 0.130 |
Why?
|
| Colitis | 1 | 2018 | 340 | 0.130 |
Why?
|
| Alu Elements | 1 | 2015 | 88 | 0.130 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 6089 | 0.130 |
Why?
|
| Gene Order | 2 | 2011 | 111 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2018 | 403 | 0.130 |
Why?
|
| Gametogenesis | 1 | 2014 | 28 | 0.130 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.120 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2014 | 15 | 0.120 |
Why?
|
| Parkinson Disease | 1 | 2021 | 708 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2022 | 925 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2021 | 1863 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 5539 | 0.120 |
Why?
|
| Language Development Disorders | 2 | 2012 | 167 | 0.120 |
Why?
|
| Osteoporosis | 1 | 2016 | 241 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 1265 | 0.120 |
Why?
|
| Codon, Initiator | 1 | 2013 | 14 | 0.120 |
Why?
|
| Genomics | 4 | 2018 | 2738 | 0.120 |
Why?
|
| Transcription Factors | 3 | 2018 | 5270 | 0.120 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 93 | 0.110 |
Why?
|
| Hepatic Encephalopathy | 1 | 2013 | 66 | 0.110 |
Why?
|
| Membrane Proteins | 3 | 2017 | 2819 | 0.110 |
Why?
|
| Brain | 4 | 2015 | 4113 | 0.110 |
Why?
|
| Free Radicals | 1 | 2012 | 62 | 0.110 |
Why?
|
| Liver Function Tests | 1 | 2012 | 173 | 0.110 |
Why?
|
| Mosaicism | 1 | 2014 | 272 | 0.110 |
Why?
|
| Aspartate Aminotransferases | 1 | 2012 | 153 | 0.110 |
Why?
|
| Sodium Benzoate | 1 | 2012 | 7 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 2063 | 0.110 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 3472 | 0.110 |
Why?
|
| Germ Cells | 1 | 2014 | 335 | 0.100 |
Why?
|
| Face | 2 | 2018 | 273 | 0.100 |
Why?
|
| Fumarates | 1 | 2012 | 30 | 0.100 |
Why?
|
| Child Behavior Disorders | 1 | 2012 | 68 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 1945 | 0.100 |
Why?
|
| Placebos | 1 | 2012 | 437 | 0.100 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2014 | 223 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 590 | 0.100 |
Why?
|
| Fragile X Syndrome | 1 | 2012 | 150 | 0.100 |
Why?
|
| Diet, Protein-Restricted | 1 | 2012 | 82 | 0.100 |
Why?
|
| Neoplasms | 5 | 2018 | 15193 | 0.100 |
Why?
|
| Organ Size | 1 | 2012 | 690 | 0.100 |
Why?
|
| Rats | 2 | 2017 | 6086 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 548 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2016 | 717 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 244 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2011 | 135 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2018 | 2203 | 0.090 |
Why?
|
| Point Mutation | 1 | 2013 | 769 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 492 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2021 | 4078 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 1390 | 0.090 |
Why?
|
| Chromosomes, Human, X | 1 | 2011 | 192 | 0.090 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2009 | 43 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 4314 | 0.090 |
Why?
|
| Aged | 6 | 2019 | 70117 | 0.090 |
Why?
|
| Exome | 1 | 2015 | 1239 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2018 | 1869 | 0.090 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2009 | 98 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 1046 | 0.080 |
Why?
|
| Penetrance | 1 | 2009 | 126 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2018 | 2669 | 0.080 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 146 | 0.080 |
Why?
|
| Inflammation | 1 | 2018 | 2522 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2009 | 231 | 0.080 |
Why?
|
| Lipids | 1 | 2012 | 644 | 0.080 |
Why?
|
| DNA Repair | 2 | 2016 | 1872 | 0.080 |
Why?
|
| Dihydroorotase | 2 | 2018 | 4 | 0.080 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 2 | 2018 | 4 | 0.080 |
Why?
|
| Aspartate Carbamoyltransferase | 2 | 2018 | 6 | 0.080 |
Why?
|
| Collagen | 2 | 2021 | 752 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 2045 | 0.080 |
Why?
|
| Lumbar Vertebrae | 2 | 2022 | 245 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2012 | 1442 | 0.070 |
Why?
|
| Intellectual Disability | 2 | 2018 | 1032 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2018 | 3518 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 2315 | 0.070 |
Why?
|
| Functional Neuroimaging | 1 | 2016 | 38 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2019 | 5710 | 0.070 |
Why?
|
| Facies | 2 | 2018 | 149 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 534 | 0.070 |
Why?
|
| Pregnancy | 3 | 2021 | 7573 | 0.070 |
Why?
|
| Autistic Disorder | 1 | 2009 | 319 | 0.070 |
Why?
|
| Glucose | 1 | 2012 | 1248 | 0.070 |
Why?
|
| Recurrence | 2 | 2014 | 4758 | 0.070 |
Why?
|
| Pedigree | 3 | 2016 | 1890 | 0.070 |
Why?
|
| Bone Remodeling | 2 | 2017 | 104 | 0.070 |
Why?
|
| Seizures | 3 | 2019 | 989 | 0.070 |
Why?
|
| Canada | 1 | 2016 | 429 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2017 | 1439 | 0.060 |
Why?
|
| Europe | 1 | 2016 | 649 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2023 | 37905 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2020 | 1764 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2017 | 974 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 2291 | 0.060 |
Why?
|
| Claudins | 1 | 2023 | 47 | 0.060 |
Why?
|
| Fracture Fixation | 1 | 2023 | 35 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 3203 | 0.060 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2012 | 67 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2019 | 1129 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 238 | 0.050 |
Why?
|
| RNA Interference | 2 | 2018 | 1408 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2018 | 2074 | 0.050 |
Why?
|
| Megalencephaly | 2 | 2012 | 56 | 0.050 |
Why?
|
| Retinal Dehydrogenase | 1 | 2021 | 91 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2009 | 862 | 0.050 |
Why?
|
| Ornithine | 2 | 2011 | 40 | 0.050 |
Why?
|
| Growth Plate | 1 | 2021 | 46 | 0.050 |
Why?
|
| DNA | 1 | 2009 | 2693 | 0.050 |
Why?
|
| Weights and Measures | 1 | 2020 | 7 | 0.050 |
Why?
|
| Biological Assay | 1 | 2022 | 177 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 4143 | 0.050 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 63 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2011 | 314 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2018 | 1546 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 7702 | 0.050 |
Why?
|
| DNA Replication | 2 | 2016 | 744 | 0.050 |
Why?
|
| Infant Mortality | 1 | 2021 | 186 | 0.040 |
Why?
|
| Catecholamines | 1 | 2019 | 101 | 0.040 |
Why?
|
| Alleles | 2 | 2016 | 2437 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2023 | 558 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 2216 | 0.040 |
Why?
|
| Hypotrichosis | 1 | 2018 | 5 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 1 | 2018 | 15 | 0.040 |
Why?
|
| COS Cells | 1 | 2019 | 377 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 273 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 2927 | 0.040 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2018 | 13 | 0.040 |
Why?
|
| Cell Movement | 2 | 2018 | 2466 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2018 | 4804 | 0.040 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2018 | 22 | 0.040 |
Why?
|
| Micrognathism | 1 | 2018 | 66 | 0.040 |
Why?
|
| SMARCB1 Protein | 1 | 2018 | 109 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 1178 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2018 | 6100 | 0.040 |
Why?
|
| Cancellous Bone | 1 | 2017 | 7 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 267 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 14551 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 73 | 0.040 |
Why?
|
| Hand Deformities, Congenital | 1 | 2018 | 87 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 328 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 585 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 2232 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 12926 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 554 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2016 | 1682 | 0.040 |
Why?
|
| Epigenomics | 1 | 2018 | 266 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 2803 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 717 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 336 | 0.040 |
Why?
|
| RecQ Helicases | 1 | 2017 | 102 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 4892 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 368 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 702 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 1130 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 287 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2016 | 82 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2018 | 434 | 0.030 |
Why?
|
| Neck | 1 | 2018 | 383 | 0.030 |
Why?
|
| Organic Anion Transporters | 1 | 2015 | 21 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 338 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2017 | 271 | 0.030 |
Why?
|
| Meiosis | 1 | 2016 | 166 | 0.030 |
Why?
|
| Chromosomes | 1 | 2016 | 244 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 137 | 0.030 |
Why?
|
| Cytosol | 1 | 2015 | 238 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 325 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2019 | 785 | 0.030 |
Why?
|
| Cell Line | 2 | 2014 | 5114 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 1052 | 0.030 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2014 | 12 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 2483 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1819 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 1183 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 717 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 1620 | 0.030 |
Why?
|
| Finite Element Analysis | 1 | 2014 | 57 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2015 | 185 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 109 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 2014 | 256 | 0.030 |
Why?
|
| Sirolimus | 1 | 2018 | 814 | 0.030 |
Why?
|
| Mitosis | 1 | 2016 | 615 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 891 | 0.030 |
Why?
|
| Fasting | 1 | 2015 | 349 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2016 | 613 | 0.030 |
Why?
|
| Birth Weight | 1 | 2015 | 374 | 0.030 |
Why?
|
| Infant Formula | 1 | 2014 | 91 | 0.030 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2014 | 126 | 0.030 |
Why?
|
| Osteopetrosis | 1 | 2013 | 26 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 239 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 2218 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2016 | 7226 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 545 | 0.030 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2013 | 37 | 0.030 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 413 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 14289 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 1467 | 0.030 |
Why?
|
| Gene Library | 1 | 2013 | 294 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2015 | 519 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2019 | 12873 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 1143 | 0.030 |
Why?
|
| Orotic Acid | 1 | 2011 | 3 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 423 | 0.030 |
Why?
|
| Nitrites | 1 | 2011 | 61 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2014 | 417 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2018 | 929 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 3570 | 0.030 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 1399 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 1547 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 21713 | 0.020 |
Why?
|
| Carboxy-Lyases | 1 | 2011 | 13 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2012 | 278 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 74 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2011 | 31 | 0.020 |
Why?
|
| Kidney | 1 | 2020 | 2146 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 1152 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2018 | 1818 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2012 | 380 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 1294 | 0.020 |
Why?
|
| Cell Division | 1 | 2014 | 2489 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2014 | 1113 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 32848 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 1338 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 1972 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 5637 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2020 | 6150 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 1038 | 0.020 |
Why?
|
| Family | 1 | 2013 | 736 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 2944 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 844 | 0.020 |
Why?
|
| United States | 1 | 2016 | 15433 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 1904 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1077 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2013 | 598 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 3441 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 1954 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 3343 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2012 | 899 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 5159 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2576 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 4821 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 2594 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 14889 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 3869 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 17523 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 7591 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 7551 | 0.010 |
Why?
|